Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

QUEST DIAGNOSTICS Aktie

 >Aktienkurs 
171.65 EUR    (TradegateBSX)
Ask: 172.1 EUR / 180 Stück
Bid: 171.2 EUR / 180 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>Performance
1 Woche: -0,2%
1 Monat: -3,6%
3 Monate: +17,1%
6 Monate: +11,3%
1 Jahr: +10,8%
laufendes Jahr: +15,1%
>QUEST DIAGNOSTICS Aktie
Name:  QUEST DIAGNOSTICS DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US74834L1008 / 904533
Symbol/ Ticker:  QDI (Frankfurt) / DGX (NYSE)
Kürzel:  FRA:QDI, ETR:QDI, QDI:GR, NYSE:DGX
Index:  S&P500
Webseite:  http://www.questdiagnosti..
Profil:  Quest Diagnostics Inc. is a leading independent provider of diagnostic testing, information, and services in the United States. The company generates the majority of its revenue from clinical testing, anatomic pathology, esoteric testing, and substan..
>Volltext..
Marktkapitalisierung:  18815.9 Mio. EUR
Unternehmenswert:  23988.47 Mio. EUR
Umsatz:  9559.78 Mio. EUR
EBITDA:  1882.5 Mio. EUR
Nettogewinn:  855.92 Mio. EUR
Gewinn je Aktie:  7.67 EUR
Schulden:  5528.82 Mio. EUR
Liquide Mittel:  363.85 Mio. EUR
Operativer Cashflow:  1633.87 Mio. EUR
Bargeldquote:  0.18
Umsatzwachstum:  -1.48%
Gewinnwachstum:  0.56%
Dividende je Aktie:  2.75 EUR
Dividendenrendite:  1.64%
Dividendenschätzung:  1.74%
Div. Historie:  13.01.26 - 0.6868€
03.10.25 - 0.6864€
>weitere anzeigen...
Insiderhandel:  5 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 5.523.819 USD.
Suchwörter:  QUEST DIAGNOSTICS, QUEST DIAGNOSTIC
Letzte Datenerhebung:  03.04.26
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 109.87 Mio. St.
Frei handelbar: 99.51%
Rückkaufquote: 1.71%
Mitarbeiter: 57000
Umsatz/Mitarb.: 0.17 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 7.74%
Bewertung:
KGV: 22.99
KGV lG: 18.61
KUV: 1.97
KBV: 3.09
PEG-Ratio: 1.6
EV/EBITDA: 12.74
Rentabilität:
Bruttomarge: 31.93%
Gewinnmarge: 8.95%
Operative Marge: 14.53%
Managementeffizenz:
Gesamtkaprendite: 6.1%
Eigenkaprendite: 14.17%
>Peer Group
Gesundheit, Onkologie/ Krebs- Behandlung
 
27.03.26 - 14:24
Quest Diagnostics Earnings Preview: What to Expect (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
18.03.26 - 16:30
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare (Zacks)
 
DGX, DVA, OPCH and ADUS gain attention as telehealth, AI adoption and aging population drive growth in home healthcare services....
18.03.26 - 13:45
Helio Genomics to Make HelioLiver™ Cancer Test Accessible to Quest Diagnostics′ Providers (PR Newswire)
 
Quest's Infrastructure to Enable Access to HelioLiver™, an AI-Powered, Blood-Based Test for Early Detection of Liver Cancer IRVINE, Calif., March 18, 2026 /PRNewswire/ -- Helio Genomics, an AI-powered TechBio company focused on early cancer detection, today announced an agreement with......
12.03.26 - 21:09
Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors (PR Newswire)
 
SECAUCUS, N.J., March 12, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced that its board of directors has elected Timothy (Tim) Wentworth, a highly seasoned business leader, to serve as a director.......
12.03.26 - 18:00
Quest Diagnostics (DGX) Down 4.2% Since Last Earnings Report: Can It Rebound? (Zacks)
 
Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
11.03.26 - 15:24
Quest Diagnostics: Wachstum durch strategische Partnerschaften und Innovation (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
10.03.26 - 15:00
Should You Continue to Hold DGX Stock in Your Portfolio? (Zacks)
 
Quest Diagnostics posts strong gains from physician and hospital channels while advancing AI-powered solutions....
07.03.26 - 02:01
Insiderhandel: SVP & General Counsel verkauft Aktien von Quest Diagnostics im Wert von 799682 USD (Insiderkauf)
 
Prevoznik, Michael E. - Vorstand - Tag der Transaktion: 2026-03-05...
07.03.26 - 02:01
Insiderhandel: SVP for Diagnostic Services verkauft Aktien von Quest Diagnostics im Wert von 588730 USD (Insiderkauf)
 
Plewman, Patrick - Vorstand - Tag der Transaktion: 2026-03-05...
07.03.26 - 02:01
Insiderhandel: SVP, Clinical Solutions verkauft Aktien von Quest Diagnostics im Wert von 538372 USD (Insiderkauf)
 
Kuppusamy, Karthik - Vorstand - Tag der Transaktion: 2026-03-04...
07.03.26 - 02:01
Insiderhandel: EVP, Regional Businesses verkauft Aktien von Quest Diagnostics im Wert von 1146115 USD (Insiderkauf)
 
Doherty, Catherine T. - Vorstand - Tag der Transaktion: 2026-03-05...
05.03.26 - 22:45
Implied Volatility Surging for Quest Diagnostics Stock Options (Zacks)
 
Investors need to pay close attention to DGX stock based on the movements in the options market lately...
05.03.26 - 01:01
Insiderhandel: SVP & General Counsel verkauft Aktien von Quest Diagnostics im Wert von 109266 USD (Insiderkauf)
 
Prevoznik, Michael E. - Vorstand - Tag der Transaktion: 2026-03-03...
05.03.26 - 01:01
Insiderhandel: CEO and President verkauft Aktien von Quest Diagnostics im Wert von 2125200 USD (Insiderkauf)
 
Davis, J. E. - Vorstand - Tag der Transaktion: 2026-03-02...
05.03.26 - 01:01
Insiderhandel: SVP for Diagnostic Services verkauft Aktien von Quest Diagnostics im Wert von 85169 USD (Insiderkauf)
 
Plewman, Patrick - Vorstand - Tag der Transaktion: 2026-03-03...
05.03.26 - 01:01
Insiderhandel: EVP, Regional Businesses verkauft Aktien von Quest Diagnostics im Wert von 131285 USD (Insiderkauf)
 
Doherty, Catherine T. - Vorstand - Tag der Transaktion: 2026-03-03...
02.03.26 - 15:06
Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results (PR Newswire)
 
New feature based on Google's Gemini seamlessly analyzes up to five years of personal lab data to help explain results and uncover potential health risks SECAUCUS, N.J., March 2, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today......
26.02.26 - 14:27
Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer (PR Newswire)
 
Veteran M&A and transformation leader from Danaher and Patheon joins the Quest Diagnostics executive team SECAUCUS, N.J., Feb. 26, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that Benjamin Beauvalot, a highly......
25.02.26 - 21:51
Portal Innovations Taps Seasoned Executive to Lead Its Newest Powered by Portal Site at the New Jersey Innovation Hub (Business Wire)
 
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Sangeetha Ramsagar has been selected as the Executive Director of the New Jersey Innovation Hub, Powered by Portal (NJIH) at the HELIX NJ. Ramsagar will lead strategy, operations, and ecosystem development for the 30,000-square-foot life sciences incubator, advancing its mission to accelerate the formation and growth of next-generation startup companies in New Jersey. Her hiring marks a key milestone as the NJIH builds dedicated leadership to support founders translating scientific discovery into scalable companies. Ramsagar brings more than 20 years of experience across pharma, biotechnology commercialization, venture strategy, and portfolio development. Most recently, she served as Founder and CEO of Kronos Health, where she advised emerging biotech companies on commercialization planning and portfolio strategy. Prior to that, she held leadership roles at Flagship Pioneering, Johnson & Johnson, Bayer Healthcare, and Quest Diagnostics, where she guided oncology and n...
25.02.26 - 16:03
Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference (PR Newswire)
 
SECAUCUS, N.J., Feb. 25, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President & Chief Financial Officer, will speak on the company's strategy, performance and the latest market......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Geizige Minister schaden dem Fürsten - allein sie sind unvermeidlich. - Königin Christine von Schweden
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!